Page last updated: 2024-08-21

indazoles and Lymphoma, B-Cell

indazoles has been researched along with Lymphoma, B-Cell in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Bhargava, P; Bouabdallah, K; Cartron, G; Danilov, AV; Davies, AJ; Dyer, MJS; Fegan, C; Hodson, DJ; Huang, X; Humeniuk, R; Jürgensmeier, JM; Li, B; Morschhauser, F; Radford, J; Rajakumaraswamy, N; Rule, SA; Salles, G; Spurgeon, S; Walter, HS; Ysebaert, L	1
Stretton, O	1
Ratain, MJ	1
Alessi, DR; Duce, SL; Fleming, S; García-Martínez, JM; Guichard, S; Preston, G; Wullschleger, S	1
Duce, SL; García-Martínez, JM; Wullschleger, S	1
Robins, HI	1

Reviews

1 review(s) available for indazoles and Lymphoma, B-Cell

Article	Year
Combined modality clinical trials for favorable B-cell neoplasms: lonidamine plus whole body hyperthermia and/or total body irradiation. Seminars in oncology, 1991, Volume: 18, Issue:2 Suppl 4 Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Humans; Hyperthermia, Induced; Indazoles; Lymphoma, B-Cell; Whole-Body Irradiation	1991

Trials

1 trial(s) available for indazoles and Lymphoma, B-Cell

Article	Year
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. Leukemia, 2021, Volume: 35, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Imidazoles; Indazoles; Lymphoma, B-Cell; Male; Middle Aged; Protein Kinase Inhibitors; Purines; Pyrazines; Pyrimidines; Quinazolinones	2021

Other Studies

4 other study(ies) available for indazoles and Lymphoma, B-Cell

Article	Year
EHA 2021 Virtual Congress. The Lancet. Haematology, 2021, Volume: 8, Issue:8 Topics: Activin Receptors, Type II; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; beta-Thalassemia; Graft vs Host Disease; Hematologic Diseases; Humans; Immunoglobulin Fc Fragments; Indazoles; Interleukin-1 Receptor-Associated Kinases; Internet; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Multiple Myeloma; Protein Kinase Inhibitors; Pyrimidines; Recombinant Fusion Proteins; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic	2021
Bar the windows but open the door to randomization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-01, Volume: 28, Issue:19 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Humans; Indazoles; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Neoplasms; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Sulfonamides; Treatment Outcome	2010
Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice. British journal of cancer, 2011, Mar-29, Volume: 104, Issue:7 Topics: AMP-Activated Protein Kinases; Animals; Indazoles; Lymphoma, B-Cell; Lymphoma, Follicular; Mice; Mice, Inbred C57BL; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; PTEN Phosphohydrolase; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases	2011
Quantitative MRI establishes the efficacy of PI3K inhibitor (GDC-0941) multi-treatments in PTEN-deficient mice lymphoma. Anticancer research, 2012, Volume: 32, Issue:2 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Female; Head and Neck Neoplasms; Indazoles; Longitudinal Studies; Lymphoma, B-Cell; Lymphoma, Follicular; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphoinositide-3 Kinase Inhibitors; PTEN Phosphohydrolase; Sulfonamides	2012